Zydus Cadila gets USFDA nod to market Fingolimod capsules, Verapamil Hydrochloride Injection

Zydus Cadila has received final approval from the United States Food
and Drug Administration (USFDA) to market Fingolimod capsules,
(Gilenya) in the strengths of 0.5 mg, Zydus Cadila, part of Cadila
Healthcare group, said in a regulatory filing.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-nod-to-market-fingolimod-capsules-verapamil-hydrochloride-injection/articleshow/78716968.cms

Comments

Popular posts from this blog

Biotecnika Times Newsletter 25.10.2021 Tata Innovation Fellowship 2021, NCCS PhD Admission

TIGS-CI Biological Sciences Research Assistant Recruitment, Apply Online